RaySearch Laboratories

RaySearch Laboratories is a Swedish medical technology company that develops software for radiation therapy and oncology workflows. Its portfolio includes treatment planning, oncology information, treatment control, and analytics software sold to cancer centers and hospitals worldwide through direct sales and distributor partnerships.

458

1.70

1.58

— RaySearch Laboratories
%
Treatment planning software45% Software used to design and optimize radiation therapy treatment plans.
Oncology information systems20% Workflow and patient-management software for radiation oncology departments.
Analytics and decision support10% Cloud-based tools for data analysis, reporting, and operational control.
Treatment control systems10% Software that links planning systems with treatment machines.
Licenses and support services15% Recurring software licenses, support, and maintenance agreements.

RaySearch sells primarily to hospitals, cancer clinics, university hospitals, and healthcare networks that deliver...

  • Public hospitals and cancer centersprimary

    Buy RayStation and RayCare to plan and manage radiation therapy for large patient volumes.

  • Private hospitals and clinicssecondary

    Buy software to improve treatment precision, workflow efficiency, and patient throughput.

  • University hospitals and academic centerssecondary

    Use the software for complex cases, clinical evaluation, and research collaboration.

  • Medical technology partnerssecondary

    Integrate RaySearch software with treatment machines and broader oncology systems.

  • Distributorssecondary

    Sell and market the software in local markets where RaySearch lacks direct reach.

RaySearch is a global business with software used in more than 1,200 clinics across 51 countries...

  • Software used in more than 1,200 clinics across 51 countries
  • Swedish headquarters with offices and subsidiaries in multiple markets
  • 19 distributors extend reach into additional countries
  • Global customer base reduces dependence on any single market
  • Local regulation and reimbursement conditions affect adoption and timing

RaySearch’s strategy centers on expanding its oncology software platform, deepening partnerships with treatment-machine...

01
Broaden adoption of the oncology software platformmedium-term

A wider installed base supports recurring licenses, support relationships, and workflow integration.

02
Deepen strategic partnershipsmedium-term

Integration with machine manufacturers and cancer centers improves product relevance and market access.

03
Apply AI to treatment planning and workflowshort-term

Automation can improve consistency, speed, and clinical utility of the software.

04
Scale global commercial executionshort-term

A distributed sales model helps reach more markets and adapt to local conditions.

RaySearch faces product-safety, cybersecurity, and talent-retention risks because its software is used in clinical...

critical

Treatment errors from software defects

The products are used in radiation therapy, where technical flaws can affect patient dose and safety.

Scope
Clinical software quality and validation
Materiality
high
high

Cyber breaches and IT disruptions

The company handles sensitive clinical and treatment data and depends on advanced IT systems.

Scope
Development, support, and data processing
Materiality
high
high

Dependence on skilled employees

Product development requires specialized medical-technology and software expertise.

Scope
Engineering, product quality, innovation
Materiality
medium
high

Competitive pressure

The market includes large established competitors investing heavily in oncology software and systems.

Scope
Pricing, customer wins, installed base growth
Materiality
high
medium

Political and market volatility

Healthcare investment and procurement can be affected by tariffs, currency restrictions, and public budgets.

Scope
Global sales and distributor markets
Materiality
medium
Revenue recognition under customer contracts
Can shift revenue between quarters and affect backlog/contract asset balances
Seasonality and lumpy order flow
Reduces quarter-to-quarter comparability
Contract assets and customer receivables
Affects working capital and credit-loss estimates
Parent company lease accounting
Creates differences in operating profit and lease-related presentation

: 11/08/2026